Neointimal Coverage on Drug-Eluting Stent Struts Crossing Side-Branch Vessels Using Optical Coherence Tomography

Division of Cardiology, Yonsei Cardiovascular Center, Yonsei University College of Medicine, Seoul, Korea.
The American journal of cardiology (Impact Factor: 3.28). 06/2010; 105(11):1565-9. DOI: 10.1016/j.amjcard.2010.01.013
Source: PubMed


The status of neointimal coverage on the drug-eluting stent (DES) struts, which are placed across the side-branch vessels, remains unclear. The degree of neointimal coverage of stent struts crossing the side-branch vessel was evaluated according to the different types of DESs. Follow-up optical coherence tomography images at 9.3 months after the index procedure were identified in 51 patients who had undergone DES (sirolimus-eluting stents [SESs] in 22 patients, paclitaxel-eluting stents [PESs] in 15, and zotarolimus-eluting stents [ZESs] in 14) implantation with crossover of the side-branch vessels (size >2.0 mm). The enrolled patients were classified as a covered group if every unapposed strut showed neointimal coverage or an uncovered group if any struts lacked neointimal coverage. The neointimal hyperplasia thickness was also measured. The number of patients in the covered group was 15 (29%), with 36 patients in the uncovered group. Significant differences were found in the proportion of the covered group among the 3 DES types (6 [27%] of 22 with SESs, 1 [7%] of 15 with PESs, and 8 [57%] of 14 with ZESs; p = 0.011). The percentage of neointimal coverage in the overall stent struts was also significantly different among the 3 DES types (65% of 356 struts, 20% of 165 struts, and 83% of 143 struts for the SESs, PESs, and ZESs, respectively; p<0.001). The neointimal hyperplasia thickness in the PES group was significantly smaller than those of the ZES and SES groups (0.02 +/- 0.02 mm vs 0.08 +/- 0.06 mm and 0.04 +/- 0.03 mm, respectively; p = 0.002). In conclusion, different patterns of neointimal coverage of the stent struts crossing the side branch vessels were observed according to the type of DES.

15 Reads
  • Circulation Journal 12/2010; 75(1):51-2. DOI:10.1253/circj.CJ-10-1147 · 3.94 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: HZSM-5 nanocrystals grafted with different alkyl groups (ethyl, butyl, hexyl, dodecyl, and hexadecyl groups) were prepared to study their stable dispersion in the hydrocarbons as well as the quasi-homogeneous catalytic activities. The physical properties of the prepared zeolites were characterized by solid-state nuclear magnetic resonance, X-ray diffraction, N2 adsorption–desorption, fourier transform infrared spectra of pyridine adsorbed, and dynamic light scattering. The results showed that the ZSM-5 crystal structure were kept without obvious change after grafting alkyl groups, but that their stable dispersions in the hydrocarbon significantly improved with increasing chain length of grafted alkyl groups by reducing aggregate size of HZSM-5 nanocrystals. Quasi-homogeneous catalytic cracking of n-dodecane at 427°C showed that the cracking rates with hydrocarbon dispersible HZSM-5 nanocrystals improved by more than 2 times compared with thermal cracking, wherein the zeolites grafted hexyl group had the best catalytic activity in good agreement with its larger acid amount.
    Applied Catalysis A General 10/2011; 405(1):61-68. DOI:10.1016/j.apcata.2011.07.028 · 3.94 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND: In the treatment of bifurcation lesions, routine stenting of both branches has thus far failed to demonstrate a clear clinical advantage over a provisional one-stent strategy. On the other hand, large scale data evaluating different stent types for clinical outcomes after one-stent treatment with final kissing inflation (FKI) of bifurcation lesions is also limited. This prospective study evaluated the clinical and angiographic outcomes of paclitaxel-eluting stents (PES) vs. sirolimus-eluting stents (SES) in single crossover main branch stenting followed by FKI in patients with bifurcation lesions. METHODS: We randomized 800 patients with single bifurcation lesions to PES (n=400) and SES (n=400) groups. RESULTS: Crossover rates to the two-stent strategy were low in both groups (PES 1.5%, SES 2.8%; p=0.23). At 1year, there was no significant difference in the primary endpoint of this study, target lesion revascularization rate (PES 3.8%, SES 3.2%, hazard ratio 0.83; 95% confidence interval 0.39 to 1.76; p=0.62). Stent thrombosis occurred in only 1 case in the SES group after 282days. At 9months, a total of 593 patients underwent quantitative coronary measurement. The main branch restenosis rate in the PES group was significantly higher than that of the SES group (PES 12.2%, SES 5.5%; p=0.004), however both groups exhibited similar high side branch restenosis rates (PES 17.2%, SES 19.3%; p=0.6). CONCLUSIONS: In patients with bifurcation lesions, a single stent strategy using PES and SES with FKI indicated similar 1year clinical outcomes and safety profiles.
    International journal of cardiology 11/2011; 166(1). DOI:10.1016/j.ijcard.2011.10.101 · 4.04 Impact Factor
Show more